Jon Weidanz, senior associate vice president of research and innovation at UTA and founding director of IMPRINT (IMAGE)
Caption
UTA’s Institute of Biomanufacturing and Precision Medicine (IMPRINT) is partnering with TEES on NCTM2, an extension of the National Center for Therapeutics Manufacturing (NCTM) in College Station. The collaboration will expand UTA’s biomanufacturing capabilities and provide NCTM2 with access to financial support and UTA’s extensive network of industry partners in the North Texas ecosystem.
Credit
UTA
Usage Restrictions
none
License
Original content